Abstract:Background Infection remains an important and leading cause of mortality in lupus. We aimed to establish a clinical prediction model for the 3 month all-cause mortality of patients with systemic lupus erythematosus (SLE) and invasive infection in the emergency department. Methods SLE patients classified by 1997 ACR criteria complicating with invasive infection when admitted into the emergency department of our center between May 2015 and June 2018 were included. Invasive infection was defined as deep infection with definite evidence of pathogens or globally judged by the treating physician combining symptoms, lab and imaging tests. Patients clinical and laboratory characteristics at admission were retrospectively collected as baseline data. The outcome was all-cause death within 3 months since baseline. Candidate predictors for multivariable logistic regression were selected by expert opinion based on clinical significance, previous studies and feasibility. A prediction model for all-cause mortality was established by combining independent predictors and evaluated by Receiver Operating Characteristic (ROC) curve analysis. Results A total of 50/130 (38.5%) included patients died cumulatively within 3 month follow-up. Patients were predominantly female (91%) with a mean disease duration of 6.6 years. One hundred and eight (83.1%) patients had lung infection, while 23 (17.7%) patients had blood stream infection. In the final multivariable logistic regression model, lymphocyte count 7.6 mmol/L, maximum prednisone dose in the past60 mg/d, qSOFA score and age at admission were independently predictive for all-cause mortality. However, the history of hydroxychloroquine use was protective. In a combined prediction model, the six predictors were weighted by OR values, making the LUPHAS score ranging from 5 to 22 (table). All patients could be categorized to three group: low-risk (score 5–10), medium-risk (score 11–16) and high-risk (score 17–22). The mortalities were 11.1% (4/36), 32.8% (22/67) and 100% (22/22) in low-risk, medium-risk and high-risk patients, respectively. ROC curve analysis indicated that LUPHAS score could effectively predict all-cause mortality in this population (AUC=0.8595%CI=0.78–0.92). Furthermore, LUPHAS score performed better than the sole qSOFA score (AUC=0.6995%CI=0.59–0.78) in our cohort. The discriminatory performance of LUPHAS score was also superior than CURB-65 score (AUC=0.6995% CI=0.59–0.80) in the subgroup of patients with lung infection (n=108). Conclusions In this large emergency cohort of lupus patients complicating with invasive infection, an impressive high mortality was recorded, underlining that special attention should be paid to these patients. Several independent predictors for all-cause mortality were successfully identified in our study. The real-world evidence-based LUPHAS score might be a promising tool for risk stratification in clinical practice. Funding Source(s): None

Infections Caused by Extended-Spectrum Β-Lactamase Producing Escherichia Coli in Systemic Lupus Erythematosus Patients: Prevalence, Risk Factors, and Predictive Model.

Molecular Characteristics of Extended-Spectrum Β-Lactamase-producing Escherichia Coli and Klebsiella Pneumoniae Causing Intra-Abdominal Infections from 9 Tertiary Hospitals in China

Analysis of the Drug Resistance of Extended-Spectrum Β-Lactamase(esbl)-producing Escherichia Coli in Cancer Patients

Antibiotic resistance of ESBLs-producing Escherichia coli and Klebsiella pneumoniae isolates and risk factors for bloodstream infections

[A Case-Control Study on Risk Factors for Nosocomial Infection by Extended-Spectrum Beta-Lactamases-producing Bacteria].

A clinical retrospective study of 130 systemic lupus erythematosus patients complicated with infections

[Patients of Escherichia Coli Bloodstream Infection: Analysis of Antibiotic Resistance and Predictors of Mortality].

THU0036 Discriminating Central Nervous System Infection and Neuropsychiatric Involvement in Patients with Systemic Lupus Erythematosus: A Single-Center Experience

Infection Profile and Risk Factors for Mortality in Patients with End-Stage Renal Disease Attributable to Systemic Lupus Erythematosus: a Two-Center Integrated Study

Development and Validation of Nosocomial Bacterial Infection Prediction Models for Patients With Systemic Lupus Erythematosus

Bulk and Single-Cell Transcriptome Analysis Reveal Shared Key Genes and Patterns of Immune Dysregulation in Sepsis and Systemic Lupus Erythematosus

A Retrospective Analysis of Risk Factors and Outcomes in Patients with Extended-Spectrum Beta-Lactamase-producing Escherichia Coli Bloodstream Infections.

Drug resistance and risk factors of extended spectrum-β lactamases producing Escherchia coli and Klebsiella pneumoniae

[Risk Factors and Prognosis in 31 Patients with Extended-Spectrum Beta-Lactamase Producing Escherichia Coli and Klebsiella Pneumoniae Bloodstream Infection].

Development and validation of a predictive model for end-stage renal disease in systemic lupus erythematosus patients

Mortality Risk Prediction in Lupus Patients Complicated with Invasive Infection in the Emergency Department: LUPHAS Score

134 Mortality risk prediction in lupus patients complicating with invasive infection in the emergency department

Klebsiella pneumoniae pneumonia in patients with rheumatic autoimmune diseases: clinical characteristics, antimicrobial resistance and factors associated with extended-spectrum β-lactamase production

1511. Utility of Clinical Scoring Models in Predicting Community Acquired Urinary Tract Infections with Extended-Spectrum β-Lactamase-Producing Escherichia coli in a General Hospital in Mexico City

Risk Factors for Antibiotic Resistance and Mortality in Patients with Bloodstream Infection of Escherichia Coli

Major Infections of Newly Diagnosed Childhood-Onset Systemic Lupus Erythematosus